Picture of Gamida Cell logo

GMDAQ Gamida Cell Cashflow Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Annual cashflow statement for Gamida Cell, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

2019
December 31st
C2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:20-F10-K10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-34.4-61.6-89.8-79.4-63
Depreciation
Non-Cash Items-8.973.535.235.45-7.55
Unusual Items
Other Non-Cash Items
Changes in Working Capital3.257.462.373.06-10.6
Change in Accounts Receivable
Change in Inventories
Change in Accounts Payable
Change in Accrued Expenses
Net Change in Other Assets & Liabilities
Other Operating Cash Flow
Cash from Operating Activities-37.9-50.2-81.8-70.4-79.1
Capital Expenditures-3.06-11.8-15.1-6.35-1.08
Purchase of Fixed Assets
Other Investing Cash Flow Items6.7213.4-45.940.40.271
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities3.671.59-60.934-0.81
Financing Cash Flow Items0.224
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities35.713471.445.161.8
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash1.5785.3-71.38.77-18.1